SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-008901
Filing Date
2019-02-19
Accepted
2019-02-19 16:57:42
Documents
4
Period of Report
2019-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv514071_6k.htm 6-K 17317
2 EXHIBIT 99.1 tv514071_ex99-1.htm EX-99.1 117758
3 EXHIBIT 99.2 tv514071_ex99-2.htm EX-99.2 13277
4 GRAPHIC image_001.jpg GRAPHIC 3852
  Complete submission text file 0001144204-19-008901.txt   154935
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 19615737
SIC: 2834 Pharmaceutical Preparations